NCT07217977

An Investigational Study Examining the Efficacy of QbMobile in Treatment Monitoring in Individuals With ADHD

• Status: Enrolling By Invitation
• Phase: —
• Study type: Observational
• Enrollment: 175 (estimated)
• Sponsor: Qbtech AB · Industry
• Sex: All
• Age: 6 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

The current study will investigate if QbMobile can be used to improve the accuracy and objective identification of reduced ADHD symptoms in tests scores once treatment has been initiated.

Detailed description

This 4-week study will evaluate QbMobile's performance in monitoring ADHD treatment response. Participants will complete the 10-minute QbMobile test on their personal device during a scheduled clinical visit. They will then repeat the test remotely the following day before beginning their ADHD medication treatment. At week 2 and week 4, participants will take QbMobile remotely at least 1 hour after taking their ADHD medication and no longer than 4 hours post dose.

Conditions

• Attention Deficit Disorder With Hyperactivity (ADHD)
• Attention Deficit Disorder (ADD)

Interventions

Type	Name	Description
OTHER	observational study	observational study

Timeline

• Start date: 2025-01-15
• Primary completion: 2026-10-01
• Completion: 2026-10-01
• First posted: 2025-10-20
• Last updated: 2025-12-31

Locations

6 sites across 1 country: United States